Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates
BETA (programming language)
Coronavirus
Booster dose
2019-20 coronavirus outbreak
DOI:
10.1126/science.abl8912
Publication Date:
2021-10-22T03:58:45Z
AUTHORS (66)
ABSTRACT
A look at variant-specific boosters The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants concern (VOCs) has raised the question whether current COVID-19 vaccines protect against VOCs and if a variant specific vaccine may be needed. Of currently identified VOCs, Delta is believed to most transmissible, whereas Beta appears resistant. Corbett et al . looked effect boosting using either original WA-1 strain or variant–specific booster. Around 6 months after primary two-dose series, third boost vaccination resulted in higher neutralizing antibody levels nonhuman primates. Regardless was from Beta-specific version, similar increases were observed enhanced viral protection. —PNK
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (88)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....